
    
      Seventy smokers who are currently alcohol dependent will be enrolled to this study. If found
      to be study eligible they will be randomized to either active varenicline or placebo for 12
      weeks. During these two weeks, they will be seen either weekly or biweekly. At the end of
      treatment, they will be followed up for an addition 12 weeks. Their last study visit will be
      6 months after randomization.
    
  